Impact of BPC-157 on Recovery Following Rotator Cuff Repair Surgery
Impact of BPC-157 on Recovery From Rotator Cuff Repair Surgery
This study is a randomized, double-blind, placebo-controlled pilot trial investigating the effects of BPC-157 on tendon healing and functional recovery following arthroscopic rotator cuff repair (aRCR). BPC-157 is a synthetic peptide that has demonstrated promising regenerative and anti-inflammatory effects in preclinical animal models of musculoskeletal injury, but it has not yet been studied in formal human clinical trials.
Twenty patients undergoing aRCR will be enrolled and randomly assigned to receive either BPC-157 or a saline placebo. Participants will self-administer subcutaneous injections daily for 90 days following surgery. All other aspects of care will follow the standard postoperative rehabilitation protocol.
The study will assess tendon healing using postoperative MRI, patient-reported outcome measures (PROMs), range of motion (ROM), and muscle strength via handheld dynamometry. Blood samples will also be collected to evaluate biomarkers associated with collagen turnover and inflammation.
The goal of this pilot study is to evaluate the safety, feasibility, and preliminary efficacy of BPC-157 in promoting tendon healing and improving functional outcomes after rotator cuff repair. Results will inform the design of a future larger-scale clinical trial.
研究概览
研究类型
注册 (估计的)
阶段
- 阶段1
联系人和位置
学习地点
-
-
Arkansas
-
Little Rock、Arkansas、美国、72205
- University of Arkansas for Medical Sciences Medical Center
-
接触:
- Shiloah Kviatkovsky
- 电话号码:619-677-0792
- 邮箱:skviatkovsky@uams.edu
-
首席研究员:
- Shiloah Kviatkovsky, P.h.D.
-
副研究员:
- Ryan Hill, M.D.
-
-
参与标准
资格标准
适合学习的年龄
- 成人
- 年长者
接受健康志愿者
描述
Inclusion Criteria:
- Males and Females, 18 years old or older
- Body mass index of 20.0 to 34.9 kg/m2
- Pre-operative MRI demonstrating a full thickness tear of the posterosuperior rotator cuff less than 2.5 cm in anteroposterior dimension
- Scheduled for an aRCR at UAMS with Dr. Ryan Hill, Dr. Paul Inclan, or Dr. Justin Rabinowitz
- COVID-19 negative and/or asymptomatic
Exclusion Criteria:
- Previous RCR
- Pregnant or breastfeeding status
- Current drug and alcohol abuse · History of platelet-rich plasma injection, other platelet-based product or biologic injection in the past 12 months in the ipsilateral shoulder
- Lack of decisional capacity
- Having undergone hormone replacement therapy in the last 12 months
- Having undergone testosterone replacement therapy in the last 12 months
- Active diagnosis of blood borne infectious disease
- Diabetic
- Documented history or diagnosis of autoimmune disease
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:四人间
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:BPC-157 Group
Participants in this arm will receive BPC-157.
BPC-157 will be self-administered via subcutaneous injection once daily for 90 days following arthroscopic rotator cuff repair.
All participants will follow the standard postoperative rehabilitation protocol in addition to the study intervention.
|
BPC-157 is a synthetic pentadecapeptide derived from human gastric juice.
It has demonstrated pro-angiogenic, cytoprotective, and tissue-regenerative effects in multiple preclinical models of musculoskeletal injury, including tendon and ligament healing.
Although widely discussed in experimental and anecdotal contexts, BPC-157 has not undergone formal human clinical trials and remains an investigational compound not approved by the FDA.
This study is designed to explore its potential role in promoting tendon regeneration and functional recovery in a postoperative orthopaedic setting.
|
|
假比较器:Sham
Participants in this arm will receive normal saline.
Normal saline will be self-administered via subcutaneous injection once daily for 90 days following arthroscopic rotator cuff repair.
All participants will follow the standard postoperative rehabilitation protocol in addition to the study intervention.
|
Participants in this group will not receive any active treatment or placebo injections.
This sham group serves as a no-treatment control to evaluate the natural course of postoperative recovery following arthroscopic rotator cuff repair without investigational intervention.
Participants will continue to receive standard postoperative care and rehabilitation in accordance with institutional protocols.
This group is included to help differentiate the effects of BPC-157 from both placebo and routine recovery.
其他名称:
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Shoulder Strength
大体时间:Baseline, 12 weeks, and 5 months post operatively
|
Isometric shoulder abduction strength will be assessed using a handheld dynamometer.
Strength measurements will focus on shoulder abduction and external rotation at 0° abduction.
Three trials will be recorded, and the average peak force will be used as the outcome value.
Testing will be performed by a blinded evaluator using a standardized protocol.
|
Baseline, 12 weeks, and 5 months post operatively
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (估计的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.